NUS 📈 Nu Skin Enterprises - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US67018T1051
NUS: Skin Care, Cosmetics, Personal Care, Wellness, Nutritional Supplements
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Web URL: https://www.nuskin.com
Additional Sources for NUS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NUS Stock Overview
| Market Cap in USD | 373m |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| GiC Sub-Industry | Personal Care Products |
| IPO / Inception | 1996-11-21 |
NUS Stock Ratings
| Growth 5y | -87.9% |
| Fundamental | -41.4% |
| Dividend | 46.2% |
| Rel. Strength Industry | -501 |
| Analysts | 3/5 |
| Fair Price Momentum | 4.74 USD |
| Fair Price DCF | 47.22 USD |
NUS Dividends
| Dividend Yield 12m | 3.64% |
| Yield on Cost 5y | 0.71% |
| Annual Growth 5y | 1.06% |
| Payout Consistency | 100.0% |
NUS Growth Ratios
| Growth Correlation 3m | 62.3% |
| Growth Correlation 12m | -91.2% |
| Growth Correlation 5y | -64% |
| CAGR 5y | -27.73% |
| CAGR/Mean DD 5y | -0.75 |
| Sharpe Ratio 12m | -1.91 |
| Alpha | -88.37 |
| Beta | 0.88 |
| Volatility | 41.96% |
| Current Volume | 2838.4k |
| Average Volume 20d | 799.5k |
What is the price of NUS stocks?
As of December 22, 2024, the stock is trading at USD 6.60 with a total of 2,838,433 shares traded.
Over the past week, the price has changed by -11.88%, over one month by -11.19%, over three months by -5.78% and over the past year by -64.96%.
As of December 22, 2024, the stock is trading at USD 6.60 with a total of 2,838,433 shares traded.
Over the past week, the price has changed by -11.88%, over one month by -11.19%, over three months by -5.78% and over the past year by -64.96%.
Is Nu Skin Enterprises a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Nu Skin Enterprises (NYSE:NUS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -41.38 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUS as of December 2024 is 4.74. This means that NUS is currently overvalued and has a potential downside of -28.18%.
Probably not. Based on ValueRay Fundamental Analyses, Nu Skin Enterprises (NYSE:NUS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -41.38 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUS as of December 2024 is 4.74. This means that NUS is currently overvalued and has a potential downside of -28.18%.
Is NUS a buy, sell or hold?
Nu Skin Enterprises has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold NUS.
Nu Skin Enterprises has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold NUS.
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecast for NUS stock price target?
According to ValueRays Forecast Model, NUS Nu Skin Enterprises will be worth about 5.1 in December 2025. The stock is currently trading at 6.60. This means that the stock has a potential downside of -22.42%.
According to ValueRays Forecast Model, NUS Nu Skin Enterprises will be worth about 5.1 in December 2025. The stock is currently trading at 6.60. This means that the stock has a potential downside of -22.42%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 8.3 | 25% |
| Analysts Target Price | 27.8 | 320.5% |
| ValueRay Target Price | 5.1 | -22.4% |